Quantcast
Channel: MassDevice
Browsing all 11157 articles
Browse latest View live

Image may be NSFW.
Clik here to view.

Amedica wins Down Under nod for Valeo interbody fusion line

Amedica (NSDQ:AMDA) said today it won regulatory clearance in Australia for its Valeo product line of interbody fusion devices. The Salt Lake City, Utah.-based company’s Valeo products are made from...

View Article


Image may be NSFW.
Clik here to view.

Novel ultrasound device dev Sonavex raises $3m

John Hopkins spin-out Sonavex said today it raised $3 million in financing, including a $2.2 million closed Series A round to support its novel ultrasound technology. The round was led by Grey Sky...

View Article


Image may be NSFW.
Clik here to view.

Sunshine Heart closes $9m offering

Sunshine Heart (NSDQ:SSH) said today it closed an underwritten public offering, bringing in approximately $9.2 million in gross proceeds. The round included the full exercise of the underwriter’s...

View Article

Image may be NSFW.
Clik here to view.

Improving the safety of imported foods through partnerships

Susan Mayne, Ph.D., Director of FDA’s Center for Food Safety and Applied Nutrition By: Susan Mayne, Ph.D., Camille Brewer, M.S., R.D., and Donald Prater, D.V.M. At FDA, we recognize that the...

View Article

Image may be NSFW.
Clik here to view.

Medtronic touts drug-coated balloon in peripheral artery disease patients

Medtronic (NYSE:MDT) touted data today for its In.Pact Admiral drug-coated balloon in 2 sub-analyses of peripheral artery disease patients in the company’s In.Pact Global Study. The data were presented...

View Article


Image may be NSFW.
Clik here to view.

Eli Lilly’s diabetes drugs boost Q1 revenue, earnings

Shares in Eli Lilly (NYSE:LLY) fell slightly today as the company met expectations on Wall Street with its 1st quarter financial results. The company has faced its share of issues in the last year –...

View Article

Image may be NSFW.
Clik here to view.

ResMed launches AirMini CPAP, touts as world’s smallest

ResMed (NYSE:RMD) today launched its AirMini continuous positive airway pressure device, touting it as the world’s smallest machine of its kind. The newly launched AirMini weighs 0.66 lbs and is small...

View Article

Image may be NSFW.
Clik here to view.

Fresenius acquires generics drugmaker Akorn, Merck’s biosimilars biz

German healthcare company Fresenius (ETR:FRE) said today that it bought U.S. generic drugmaker Akorn Inc. (NSDQ:AKRX) for $4.75 billion and Merck KGaA’s biosimilars business. Since chief executive...

View Article


Image may be NSFW.
Clik here to view.

Allergan wins FDA nod for TrueTear tear-inducing neurostim

Allergan (NYSE: AGN) said today it won FDA clearance for its TrueTear intranasal tear neurostimulator designed to stimulate tear production, touting it as the 1st of its kind. The TrueTear device is...

View Article


Image may be NSFW.
Clik here to view.

3M posts Street-beating Q1 results, updates full-year guidance

Shares in 3M (NYSE:MMM) rose today after the company met expectations on Wall Street with its 1st quarter results. The St. Paul, Minn.-based company posted profits of $1.32 billion, or $2.16 per share,...

View Article

Image may be NSFW.
Clik here to view.

ALung submits FDA IDE app for HemoLung device

ALung Technologies said today it submitted an investigational device exemption application to the FDA as it seeks to begin a clinical study of its Hemolung Respiratory Assist System. The Pittsburgh,...

View Article

Image may be NSFW.
Clik here to view.

How medtech companies can benefit from agile marketing

[Image from unsplash.com]Getting a medical device to market can be tough. It has to go through several hoops at the FDA, including the 5-step premarket requirements that include: classifying the...

View Article

Image may be NSFW.
Clik here to view.

Tela Bio launches post-clinical OviTex ventral hernia repair study

Tela Bio said today it initiated a post-market clinical study of its OviTex reinforced bioscaffold designed for soft tissue repair, enrolling the 1st patient at La Jolla, Calif.’s Scripps Clinic. The...

View Article


Image may be NSFW.
Clik here to view.

Reva plans $40m convertible note offering

Reva Medical (ASX:RVA) said yesterday that it’s planning a $40 million convertible note offering with several institutional and 1 undisclosed corporate investor to fund the company’s ongoing needs,...

View Article

Image may be NSFW.
Clik here to view.

Ivantis launches 2nd IDE study of Hydrus microstent

Ivantis said today it won approval from the FDA to initiate a 2nd investigational device exemption trial of its Hydrus microstent, testing the device in patients with advanced glaucoma who are...

View Article


Image may be NSFW.
Clik here to view.

Novartis misses on rev, tops sales estimates in Q1

Shares in Novartis (NYSE:NVS) rose today after the pharmaceutical company met expectations on Wall Street with its 1st quarter earnings, but missed on sales largely thanks to growing pressure from...

View Article

Image may be NSFW.
Clik here to view.

GE Healthcare, Lantheus ink PET imaging agent development deal

GE Healthcare (NYSE:GE) and Lantheus Holdings(NSDQ:LNTH) said today they inked a definitive license agreement to continue the Phase III development and commercialization of the investigational...

View Article


Image may be NSFW.
Clik here to view.

MassDevice.com +5 | The top 5 medtech stories for April 25, 2017

Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s...

View Article

Image may be NSFW.
Clik here to view.

Spirox touts 1-year 1st-in-human study results of Latera nasal implant

Spirox today released 1-year data from the 1st-in-human study of its Latera absorbable nasal implant designed to support nasal cartilage and prevent nasal valve collapse, which can contribute to nasal...

View Article

Image may be NSFW.
Clik here to view.

Report: Pharma relies on price hikes for growth

Despite growing pressure from lawmakers over the pharmaceutical industry’s pricey products, new research shows that pharma relied largely on price hikes for growth in 2016. A 120-page report from...

View Article
Browsing all 11157 articles
Browse latest View live


Latest Images